Skip to main content
. Author manuscript; available in PMC: 2017 Apr 4.
Published in final edited form as: Value Health. 2017 Jan 10;20(1):2–14. doi: 10.1016/j.jval.2016.11.005

Table 3.

Considerations in defining the context of use of ClinRO assessments.

Disease definition (including, if appropriate)

  • Pathogenesis

  • Disease subtype

Targeted subpopulations

  • Patients’ demographic characteristics

  • Disease severity

  • History of previous treatment

  • Culture and language

Clinical trial design and objectives

  • End point model

  • End point definitions

  • Analysis plan

  • Targeted labeling

Study setting

  • Inpatient vs. outpatient

  • Geographic location

  • Clinical practice variation

ClinRO, clinician-reported outcome.